Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [31] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [32] COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
    Jalkanen, Pinja
    Kolehmainen, Pekka
    Hakkinen, Hanni K.
    Huttunen, Moona
    Tahtinen, Paula A.
    Lundberg, Rickard
    Maljanen, Sari
    Reinholm, Arttu
    Tauriainen, Sisko
    Pakkanen, Sari H.
    Levonen, Iris
    Nousiainen, Arttu
    Miller, Taru
    Valimaa, Hanna
    Ivaska, Lauri
    Pasternack, Arja
    Naves, Rauno
    Ritvos, Olli
    Osterlund, Pamela
    Kuivanen, Suvi
    Smura, Teemu
    Hepojoki, Jussi
    Vapalahti, Olli
    Lempainen, Johanna
    Kakkola, Laura
    Kantele, Anu
    Julkunen, Ilkka
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [33] COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
    Pinja Jalkanen
    Pekka Kolehmainen
    Hanni K. Häkkinen
    Moona Huttunen
    Paula A. Tähtinen
    Rickard Lundberg
    Sari Maljanen
    Arttu Reinholm
    Sisko Tauriainen
    Sari H. Pakkanen
    Iris Levonen
    Arttu Nousiainen
    Taru Miller
    Hanna Välimaa
    Lauri Ivaska
    Arja Pasternack
    Rauno Naves
    Olli Ritvos
    Pamela Österlund
    Suvi Kuivanen
    Teemu Smura
    Jussi Hepojoki
    Olli Vapalahti
    Johanna Lempainen
    Laura Kakkola
    Anu Kantele
    Ilkka Julkunen
    Nature Communications, 12
  • [34] CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout
    Gupta, Rahul
    Kazi, Tawsif Ahmed
    Dey, Dhritiman
    Ghosh, Arijit
    Ravichandiran, V.
    Swarnakar, Snehasikta
    Roy, Syamal
    Biswas, Swadesh Ranjan
    Ghosh, Dipanjan
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 105 (20) : 7593 - 7605
  • [35] CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout
    Rahul Gupta
    Tawsif Ahmed Kazi
    Dhritiman Dey
    Arijit Ghosh
    V. Ravichandiran
    Snehasikta Swarnakar
    Syamal Roy
    Swadesh Ranjan Biswas
    Dipanjan Ghosh
    Applied Microbiology and Biotechnology, 2021, 105 : 7593 - 7605
  • [36] A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
    Counoupas, Claudio
    Johansen, Matt D.
    Stella, Alberto O.
    Nguyen, Duc H.
    Ferguson, Angela L.
    Aggarwal, Anupriya
    Bhattacharyya, Nayan D.
    Grey, Alice
    Hutchings, Owen
    Patel, Karishma
    Siddiquee, Rezwan
    Stewart, Erica L.
    Feng, Carl G.
    Hansbro, Nicole G.
    Palendira, Umaimainthan
    Steain, Megan C.
    Saunders, Bernadette M.
    Low, Jason K. K.
    Mackay, Joel P.
    Kelleher, Anthony D.
    Britton, Warwick J.
    Turville, Stuart G.
    Hansbro, Philip M.
    Triccas, James A.
    NPJ VACCINES, 2021, 6 (01)
  • [37] SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
    Paddy Ssentongo
    Anna E. Ssentongo
    Navya Voleti
    Destin Groff
    Ashley Sun
    Djibril M. Ba
    Jonathan Nunez
    Leslie J. Parent
    Vernon M. Chinchilli
    Catharine I. Paules
    BMC Infectious Diseases, 22
  • [38] A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
    Claudio Counoupas
    Matt D. Johansen
    Alberto O. Stella
    Duc H. Nguyen
    Angela L. Ferguson
    Anupriya Aggarwal
    Nayan D. Bhattacharyya
    Alice Grey
    Owen Hutchings
    Karishma Patel
    Rezwan Siddiquee
    Erica L. Stewart
    Carl G. Feng
    Nicole G. Hansbro
    Umaimainthan Palendira
    Megan C. Steain
    Bernadette M. Saunders
    Jason K. K. Low
    Joel P. Mackay
    Anthony D. Kelleher
    Warwick J. Britton
    Stuart G. Turville
    Philip M. Hansbro
    James A. Triccas
    npj Vaccines, 6
  • [39] Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
    Cao, Lirong
    Lou, Jingzhi
    Chan, See Yeung
    Zheng, Hong
    Liu, Caiqi
    Zhao, Shi
    Li, Qi
    Mok, Chris Ka Pun
    Chan, Renee Wan Yi
    Chong, Marc Ka Chun
    Wu, William Ka Kei
    Chen, Zigui
    Wong, Eliza Lai Yi
    Chan, Paul Kay Sheung
    Zee, Benny Chung Ying
    Yeoh, Eng Kiong
    Wang, Maggie Haitian
    NATURE MEDICINE, 2022, 28 (08) : 1715 - +
  • [40] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021
    Plumb, Ian D.
    Fette, Lida M.
    Tjaden, Ashley H.
    Feldstein, Leora
    Saydah, Sharon
    Ahmed, Amina
    Link-Gelles, Ruth
    Wierzba, Thomas F.
    Berry, Andrea A.
    Friedman-Klabanoff, DeAnna
    Larsen, Moira P.
    Runyon, Michael S.
    Ward, Lori M.
    Santos, Roberto P.
    Ward, Johnathan
    Weintraub, William S.
    Edelstein, Sharon
    Uschner, Diane
    VACCINE, 2023, 41 (15) : 2596 - 2604
12345